Fibroblast Growth Factors 3 (FGF-3) and 4 (FGF-4) were compared for the eects they each exert on EF43 mouse cells. This non-transformed mammary cell line appears to be myoepithelial mainly because it expresses a-smooth muscle actin. The EF43 cells were infected with similar vectors that carry either the short fgf-3 sequence (the product of which goes into the secretory pathway), fgf-4 or the selection gene only as control. In syngeneic animals, EF43.fgf-3 cells were tumorigenic only when orthotopically implanted whereas EF43.fgf-4 cells invariably gave rise to aggressive tumors. However, both tumor types were metastatic as evidenced by the blue micrometastases observed when the implanted cells expressed lacZ. In vitro, the FGF-3 producing cells were strongly invasive in matrigel coated chambers whereas the EF43.fgf-4 cells only were invasive in type I-collagen gels. Interestingly, FGF-3 production greatly stimulated the synthesis of pro-MMP-9 (Matrix Metalloprotease-9) and, to a lesser extent, that of pro-MMP-2. FGF-3 also up-regulated the production of plasminogen activators. In contrast, FGF-4 had no eect on these secretions and the medium conditioned by the EF43.fgf-4 cells displayed the largest plasminogen activator ± inhibitor activity. These results show that FGF-3 and FGF-4 have distinct mechanisms of action on myoepithelial cells.
Introduction
A characteristic feature of mouse mammary tumorigenesis is the primary role that members of the ®broblast growth factor (FGF) family play in the process. The int-2 gene (fgf-3) was discovered because it is a main target for mouse mammary tumor virus (MMTV) insertional activation in mouse mammary tumoral cells (Peters et al., 1983; Dickson et al., 1984) . The hst gene (fgf-4), ®rst identi®ed as a dominant oncogene (Delli Bovi et al., 1987) , was found to be also activated in mouse mammary tumors (Peters et al., 1989) albeit at a much lower frequency than fgf-3. Expression of fgf-4 in mouse mammary tumoral cells was associated with the acquisition of a metastatic phenotype (Murakami et al., 1990) . Mice transgenic for fgf-3 or fgf-7 were obtained in which the transgene expression was targeted to the mammary gland by the MMTV promoter. In these mice, FGF-3 and FGF-7 acted as epithelial growth factors inducing mammary hyperplasias; cancer, however, developed unfrequently and at a relatively advanced age (Muller et al., 1990; Kitsberg and Leder, 1996) . In contrast, mammary carcinomas developed early at high frequency in doubly transgenic animals expressing wnt-1 in addition to fgf-3 (Kwan et al., 1992) . This result demonstrated the cooperation between the fgf-3 and wnt-1 gene products. This phenomenon was previously observed in naturally infected mice which showed concomitant activation of the two genes in a large percentage of tumors (Peters et al., 1986) . Striking results were then obtained when wnt-1 transgenic mice were infected by MMTV. In the tumors developed by these mice, insertional MMTV activation occurred in fgf-3, fgf-4 (Shackleford et al., 1993) , and the involvement of still another member of the FGF family, namely FGF-8, was discovered (MacArthur et al., 1995; Kapoun and Shackleford, 1997) .
As it stands now, the FGF family comprises 10 characterized growth regulatory proteins that share 35 ± 50% overall homology (reviews in Basilico and Moscatelli, 1992; Goldfarb, 1996 , and for FGF-10: Yamasaki et al., 1996) . FGF-3 to 8 and FGF-10 are each synthesized with a signal peptide which transports them to the secretory pathway, whereas FGF-1, -2 and -9 which lack a signal peptide, are released from the cells by unknown mechanisms. FGFs were ®rst characterized by their heparin-binding properties. The heparan sulfate proteoglycans of the extracellular matrix are their low anity receptors and the FGF signal is then transmitted by transmembrane tyrosine kinases that act as high anity receptors. Four genes encode the high anity receptors, FGFR-1 to -4, but alternative splicing generates at least 60 isoforms of the proteins. Thus, FGF-3 binds mainly to the IIIb isoforms of FGFR-1 and FGFR-2 (Mathieu et al., 1995) whereas FGF-4 binds to the IIIc isoforms of FGFR-1, -2 and -3 (Kanai et al., 1997) and to FGFR-4 (Ornitz et al., 1996; review in Goldfarb, 1996) .
Our work is focused on the mode of action of FGF-3 on cells of mammary origin. Recently, we established an in vivo model for the tumorigenicity of mouse mammary cells expressing fgf-3 and we compared the properties of these cells to those of cells expressing fgf-4 from a similar construct (Hajitou and Calberg-Bacq, 1995) . We used the non-transformed EF43 cell line that had emerged in vitro as a clonal outgrowth in an Epithelial Focus assay from the mammary gland of a totally g-irradiated Balb/c mouse (Adams et al., 1987) . These cells were able to repopulate the cleared mammary fat pad of syngeneic mice and to dierentiate in vivo upon hormonal stimulation (GuÈ nzburg et al., 1988) . fgf-3 and fgf-4 each were introduced in EF43 cells by means of retroviral vectors. The short fgf-3 sequence which was used, starts at the AUG codon and its product enters the secretory pathway (Acland et al., 1990) . EF43 cells are sensitive to FGF action as shown by the growth factor eect that FGF-3 and FGF-4 exert on EF43 cells in vitro. However, FGF-4-producing cells only were morphologically transformed and they grew in soft agar. In vivo, EF43.fgf-3 cells were tumorigenic in nude mice but only after orthotopic implantation, whereas FGF-4 producing EF43 cells were highly tumorigenic irrespective of the site of implantation in nude mice (Hajitou and Calberg-Bacq, 1995) .
In the present work, FGF-3 and FGF-4 producing EF43 cells were probed for tumorigenicity in syngeneic animals and metastatic potential. As an attempt to correlate these in vivo properties to phenotypic features classically associated with increased tumorigenicity, the various cell populations were submitted to in vitro invasion tests and the conditioned media were analysed for the presence of the main proteases involved in extracellular matrix degradation, i.e. the matrix metalloproteases (MMPs) and the plasminogen activators (PAs). The results obtained greatly varied depending on whether the cells were producing FGF-3 or FGF-4, highlighting the dierences in the mode of action of these two growth factors. We also found that EF43 cells have characteristics of myoepithelial cells, a property that may be related to the way these cells respond to FGF-3 and FGF-4.
Results

The EF43 parental cell line are myoepithelial cells
The epithelial origin of the EF43 cell line derived from a BALB/c mouse mammary gland, was initially validated by the positive immuno¯uorescence reaction Figure 1 Characterization of the EF43 mouse mammary cells. Indirect immuno¯uorescence staining was performed using an antia-smooth muscle actin antiserum on (a) the EF43.C cells and (b) frozen sections of a mouse mammary gland. EF43.C cells were also positively stained with (c) an anti-laminin antiserum or (d) an anti-type IV collagen antiserum. Scale bars=10 mm FGF-3 and FGF-4 oncogenic properties A Hajitou et al obtained with a pan-cytokeratin antiserum (Hajitou and Calberg-Bacq, 1995) . However, using an antiserum against a-smooth muscle actin, the EF43 parental cells and all the infected derivatives also gave a strong positive immuno¯uorescence staining ( Figure 1a ). Myoepithelial cells are known to express both cytokeratins (Franke et al., 1980) and a-smooth muscle actin (Gugliotta et al., 1988 and the control mouse mammary gland in Figure 1b ). In agreement with this myoepithelial character (review in RonnovJessen et al., 1996) , EF43 cells were not stained by antisera against epithelial-membrane-antigen (EMA) and cytokeratin-18 (not shown). Yet, the EF43 cells and all their derivatives strongly expressed type IV collagen and laminin which are also characteristic features of myoepithelial cells (Figure 1c and d) . The question of whether this phenotype was present at the time the EF43 cell line was isolated or the cells had evolved during culture, is left open. Using Scatchard's method (1949) for the detection of estrogen receptors, radioactively labeled estradiol did not bind to the cytosol of the parental EF43 cells or their derivatives. In contrast, the cytosol from human breast cancer cells gave a positive result in a simultaneous test. Thus, the EF43 cells have no estrogen receptors.
As shown by immuno¯uorescence staining, the fgf-3 and fgf-4 gene products were present in the infected EF43 cells. EF43.fgf-3 and EF43.fgf-4 were heavily stained for FGF-3 and FGF-4, respectively, and these proteins were strictly located in the cytoplasm (Figure 2) . A major feature of the EF43.fgf-4 cells is their spindleshape morphology, in striking contrast with the parental and EF43.fgf-3 cell morphology (Hajitou and CalbergBacq, 1995) . Because of this ®broblastic morphotype, the expression of cell ± cell adhesion molecules was thus investigated in the EF43.fgf-4 cells. Using an anti-pancadherin antiserum, the presence of cadherin in association with b-catenin in EF43 and derivative cells was demonstrated by Western blotting (Figure 3a ). This experiment also showed that the cadherin amount that is associated with b-catenin, was decreased in the FGF-4 producing EF43 cells. With more speci®c reagents, the EF43 cells were found not to express E-or P-cadherin (Figure 3b and c) . All the cells produced a-and b-catenin (Figure 3c ) and the cadherin type that is associated with b-catenin in the EF43 cells is under current study. The acatenin and b-catenin staining in the EF43 cell lines shows an interrupted pattern at the cell ± cell borders, which was called`hesitating' (Spieker et al., 1995) and is not necessarily accompanied by a downregulation of the protein production.
Tumorigenicity
Tumorigenicity of the EF43.fgf-3 cells was tested in syngeneic animals. The cells (2610 6 ) were injected in young Balb/c female mice, either subcutaneously or in the mammary fat pad. After subcutaneous inoculation, no tumor developed in mice kept for 6 months. In contrast, tumors appeared at all injection points in the mammary gland after around 20 days, and they grew regularly (Figure 4 ). Under identical conditions, the control EF43.C cells always failed to induce tumors. As expected, EF43.fgf-4 cells gave rise to rapidly growing tumors already visible 4 days after implantation either subcutaneously (data not shown) or in the mammary fat pad (Figure 4) .
We then tested the in¯uence of the fgf-3 expression level on the tumorigenic properties of the EF43.fgf-3 cells. For that purpose, 10 isolated clones were propagated and their fgf-3 speci®c mRNA contents were compared by dot blotting (Figure 5 , insert). Three clones exhibiting various fgf-3 mRNA levels were selected and their tumorigenicity was determined in nude mice. No clone developed subcutaneously but tumors from the three clones appeared at the same time in the mammary fat pad and they grew similarly ( Figure 5) . Clearly, the level of tumorigenicity and the requirement for a mammary environment are characteristic properties of the FGF-3 producing EF43 cells. These properties are induced by FGF-3 amounts that are lower than those present in our EF43.fgf-3 cell population. An EF43-C clone was propagated in Examination of frozen sections showed that all cells in tumors originating from EF43.fgf-3 and EF43.fgf-4 were positive for a-smooth actin (not shown). Irrespective of the stage of tumor development, the tumoral cells were strongly stained for FGF-3 and FGF-4 in the EF43.fgf-3 and EF43.fgf-4 tumors, respectively, showing that growth factor gene expression was not decreased or shut o during tumor progression (data not shown).
Metastatic potential
In the experiments described above, the tumor-bearing mice were sacri®ced before they died because of the large * Figure 3 Expression of cadherin and catenins by the EF43 cells and their infected variants. Western blotting on b-catenin immunoprecipitates performed on EF43 (lane 1), EF43.fgf-3 (lane 2) and EF43.fgf-4 (lane 3) with (a) a pan-cadherin antibody and (b) a P-cadherin antibody. The HaCa-4 cell line (lane 4), expressing mouse P-cadherin (Navarro et al., 1993) , was used as positive control. *Indicates a 120 kDa cadherin band. IB: Immunoblotting. In (c), immunochemical detection of (left panels) mouse Ecadherin using DECMA-1 antiserum, (middle panels) a-catenin and (right panels) b-catenin on EF43 cells (row 1), EF43.fgf-3 cells (row 2) and EF43.fgf-4 cells (row 3). The NMe cell line that expresses mouse E cadherin in complex with both a-and b-catenin , was used as positive control (row 4) volume reached by the tumors (4 weeks for mice bearing EF43.fgf-4 tumors and 12 weeks for mice bearing EF43.fgf-3 tumors). In these mice, metastases could not be detected macroscopically or by microscopic observation of dissected organs. We then used the bgalactosidase-encoding lacZ gene to mark the tumoral cells and to detect possible micrometastases (Lin et al., 1990) . G418 resistant EF43-lacZ colonies obtained after infection of EF43 cells with retroviral vectors carrying the Bag plasmid (Price et al., 1987) , were ®rst isolated and screened for b-galactosidase activity. A clonal EF43.lacZ cell line exhibiting a high X-gal positivity was established and repeatedly infected with the control retroviral vectors and those carrying fgf-3 or fgf-4, giving rise to EF43.lacZ.C, EF43.lacZ.fgf-3 and EF43.lacZ.fgf-4 cell populations, respectively. These cell populations were each inoculated (10 7 cells, ®ve times more than in the preceeding experiments) in nude mice mammary fat pads. The control cells did not give rise to any tumor. Animals bearing tumors were sacri®ced 5 ± 6 weeks after injection of EF43.lacZ.fgf-4 cells and 12 ± 13 weeks after injection of EF43.lacZ.fgf-3 cells. Staining for bgalactosidase activity was performed in toto on a tumor as well as on various organs removed from tumorbearing mice. The tumor appeared completely blue and individual micrometastases were observed microscopically in lungs of mice bearing EF43.lacZ.fgf-3 or EF43.lacZ.fgf-4 cell tumors (Figure 6a and b). On frozen sections, some micrometastases were detected in the liver of EF43.lacZ.fgf-4 tumor bearing mice, and very few micrometastases in the spleen from EF43.lacZ.fgf-3 tumor bearing mice (Figure 6c to f). In both FGF-3 and FGF-4 cases, micrometastases consisted of small clusters of blue cells; this type of staining was not detected in organs of mice inoculated with EF43.lacZ.C cells.
MMP-2 and MMP-9 secretion
The production of metalloproteases-2 (MMP-2, gelatinase A) and -9 (MMP-9, gelatinase B) is associated with the invasive phenotype of many cellular types because they degrade type IV collagen, a component of natural basement membranes that is also present in matrigel. The media conditioned by the three cell types were therefore examined by zymography for the presence of the 72 kDa pro-MMP-2 and the 105 kDa pro-MMP-9 (in mouse, Tanaka et al., 1993 , whereas the human pro-MMP-9 is a 92 kDa protein). Both the control EF43.C and the parental EF43 cells secreted some amounts of pro-MMP-9 and very little amounts pro-MMP-2 (ten times less). These activities were observable by zymography only on conditioned media concentrated by lyophilyzation (Figure 7a ). This basal production of pro-MMPs -9 and -2 was also observed in the EF43.fgf-4 cell conditioned medium. In contrast, the EF43.fgf-3 cell medium revealed very large amounts of pro-MMP-9 and large amounts of pro-MMP-2 (Figure 7b ), thus demonstrating that the endogenous production of FGF-3 stimulates pro-MMP-9 and -2 secretion by a factor of 10 or more.
To test their ability to activate metalloproteases, the cells were cultured in presence of 10 ± 50 ng of 12-Otetradecanoylphorbol-13-acetate (TPA) which is known to induce MMP-2 activation and to increase pro-MMP-9 production (Sato et al., 1992) . The treatment did not result in the appearance of active MMP-2 form and it caused a slight MMP-9 increase, as expected ( Figure 7c ). We also searched for a possible MMP activation by type I and type IV collagens, by culturing the cells on these extracellular matrix components under conditions known to favor the induction of an invasive phenotype (Azzam et al., 1993) . However, active MMP forms were not observed (data not shown).
u-PA, t-PA and PAI activities
The presence of plasminogen activator (u-PA and t-PA) and plasminogen activator inhibitor (PAI) activities in conditioned media obtained from EF43.C, EF43.fgf-3 and EF43.fgf-4 cells, was investi- gated by using a colorimetric assay that discriminates between t-PA and u-PA and measures uncomplexed PAI (Leprince et al., 1989) . As shown in Figure 8 , all these activities were detected in the conditioned medium from the control EF43.C cells but at a very low level. In contrast, the EF43.fgf-3 cell medium exhibited a very important (at least ten times increased) PA activity that mainly occurred under the t-PA form (Figure 8a) . The EF43.fgf-4 cell conditioned medium contained the largest PAI activity (Figure 8b ). Because the test detects free PAI activity, this property might be linked with the fact that FGF-4 stimulates t-PA activity to a lower level than FGF-3.
In vitro invasive properties
To characterize properties that may relate cellular secretions on culture dishes and in vivo tumorigenesis, we examined the invasive potential of the EF43 variant cell populations using three types of in vitro cell invasion assays. In the`precultured heart fragment' assay, the parental cells invaded as solitary cells and they did not grow (Table 1 ). Both transformed EF43 cell variants invaded progressively and grew when in contact with the precultured heart fragments, showing some increased invasiveness but no dierence between the FGF-3-and FGF-4-producing cells (Table 1) .
The cells were then tested for their ability to migrate through matrigel-coated porous membranes inserted into Boyden chambers. These assays revealed striking dierences between the three cell types (Figure 9 ). EF43-C cells invaded matrigel very weakly and a migration time of 36 h was chosen to allow some control cells to be counted. EF43.fgf-3 cells displayed a very high, 25-fold increased, invasive ability by reference to the EF43.C cells. The invasive potential of EF43.fgf-4 was also increased, but, very interestingly, to a lesser extent than that of the FGF-3 producing cells.
Finally, a third assay was used to test the in vitro invasive potential of the EF43.fgf-3, EF43.fgf-4 and EF43 parental cells, into type I-collagen gel . MCF7/AZ cells used as negative control cells did not enter the gel. The highly invasive positive control (DHB ± FIB, DimancheBoõÈ trel et al., 1994) gave an invasion index of 13% with a mean cell depth of 41.5 mm ( Table 2) . The EF43 and EF43.fgf-3 cells displayed low invasion indices. At variance with the results of the Boyden assay, the EF43.fgf-4 cells were those which had the greatest collagen-I invasive potency ( Table 2 ). In vitro Boyden assays on matrigel. Cells (10 4 ) were seeded in the upper compartment of Boyden chambers to test their ability to migrate through matrigel-coated ®lters inserted into the chambers. After a 36 h incubation, the mean number of migrated cells/membrane was determined. Each cell population (EF43.C, EF43.fgf-3 and EF43.fgf-4, as indicated) was tested at least twice and each test was performed in triplicate (2) III (3) III (2);IV (1) III (1);IV (2) Monolayer fragments were confronted with precultured heart fragments for 4 and 7 days. Histological evaluation was performed by three independent observers and invasion was scored according to Bracke et al. (1993) ; grades I and II mean no occupation of the cardiac muscle and absence of invasion whereas grades III and IV indicate invasion because confronted cells are replacing less or more of the heart cells, respectively. The number of cultures are in parenthesis The cells were incubated during 24h on the top of type I collagen gel. The invasion index was calculated as the number of deep cells over the total number of cells counted (deep plus super®cial). The depth of invasion inside the gel was determined by microscopy. The cell lines, MCF7/AZ (derived from an invasive breast cancer) and DHD-FIB (rat colon tumor myo®broblasts) were used as negative and positive controls, respectively FGF-3 and FGF-4 oncogenic properties A Hajitou et al salivary glands (Skalli et al., 1986; Gugliotta et al., 1988) . Using various antisera, other features of the EF43 cells are revealed which distinguish them from the luminal cells (as reviewed by Ronnov-Jenssen et al., 1996) . On the basis of these results, we consider that the EF43 cell line cloned from a mammary gland primary cell culture, is myoepithelial. The cell line may have been isolated as such or it may have evolved from a stem cell line expressing the myoepithelial differentiation program or alternatively, it may have undergone modi®cations during culture since mouse mammary cells are known for their very labile phenotype (Smalley et al., 1995) . Our results ®rst show that EF43 cells respond to FGF growth factors. Their myoepithelial character might be important in this respect. Indeed, the rat and human mammary myoepithelial cells produce FGF-2; they also possess low and high anity FGF-2 receptors in marked contrast to the epithelial cells (Gomm et al., 1991; Fernig et al., 1995) . Production of both FGF-2 and its receptors is induced during the dierentiation of rat or human mammary epithelial cells into myoepithelial cells (Barraclough et al., 1990; Fernig et al., 1990; Ke et al., 1993) . The FGFR-2 IIIb receptor which binds FGF-1, FGF-3 and FGF-7 is present on human mammary myoepithelial and epithelial cells (Bansal et al., 1997) .
Previously, we found that FGF-3 producing-EF43 cells were tumorigenic when implanted in the mammary tissue of nude mice. This model is now validated in syngeneic animals. The time course of the FGF-3 tumor appearance is very characteristic. Indeed, the EF43.fgf-3 cell population as three clones that express various fgf-3 levels, give rise to tumors that develop exactly in the same way. The rapid growth of the tumors induced by EF43.fgf-4 cells is also characteristic and consistent with the known oncogenic properties of FGF-4 (McLeskey et al., 1993) .
To examine the metastatic properties of the EF43.fgf-3 and EF43.fgf-4 cells, we used the lacZ gene to tag the tumoral cells. In that test, both the FGF-3 and the FGF-4 tumors were found to give rise to micrometastases in various organs showing that the EF43 cells expressing either FGF-3 or FGF-4 are able to metastasis.
Assays were then carried out to ®nd the phenotypic properties that the EF43 cells acquire by fgf-3 expression and which could account, at least in part, for their increased tumorigenicity. The result was that cells producing FGF-3 or FGF-4 dier markedly (as summarized in Table 3 ), demonstrating that FGF-3 has its own mode of action and that its eect is not simply similar but weaker than that of FGF-4. In matrigel invasion assay, the FGF-3-producing cells were much more invasive than the FGF-4-producing ones. This property might be due to their increased secretion of proteolytic enzymes if one assumes that matrigel contains enzymatic activities able to activate the secreted pro-MMPs. In the type I collagen invasion assays, the FGF-4 producing cells are highly invasive, a property that may be related to cell motility more than to proteolytic activity . Discrepancies in cellular invasiveness measured in various in vitro tests, are likely to be observed since the cells are brought into dierent microecosystems in which dierent factors may promote or counteract invasion .
Concerning the metalloproteases, the parental EF43 cells secrete low amounts of pro-MMP-2 and somewhat more pro-MMP-9. This observation is in agreement with the results of Andersson et al. (1994) who showed that myoepithelial cells, but not luminal cells, are a major source of metalloproteases in the rat mammary gland. Very characteristically, this basal secretion is strongly up-regulated by FGF-3 production in EF43 cells. On the other hand, the expression of the tissue inhibitors of metalloproteases TIMP-1 and TIMP-2 We could not detect any mature MMP-9 or -2, nor could we induce activation of the pro-MMPs -9 or -2 that are secreted by the EF43 cells, suggesting that the cells do not synthesise membrane-bound activators. In vivo however, they could trigger stromal cells to produce MMP activators and/or they could produce plasmin in the presence of plasminogen. Plasmin is known to activate pro-MMPs (review in Ries and Petrides, 1995) . Plasminogen activators are also strongly up-regulated in the FGF-3-producing cells. (The fact that it is t-PA and not u-PA which is mainly induced, might be mousespecies speci®c.) On the rat mammary myoepithelial cells, FGF-2 increases the secretion of both MMP-9 and u-PA (Andersson et al., 1994; Warburton et al., 1996; Miyake et al., 1996) . However, this eect is not general to the FGFs; indeed, the EF43.fgf-4 cell conditioned medium is not enriched in MMPs but on the contrary, it has an elevated PAI activity.
Recently, we demonstrated that the synthesis of vascular endothelial growth factor (VEGF) is strongly up-regulated in the FGF-4 producing EF43 cells but not in the control nor in the FGF-3 producing cells (Deroanne et al., 1997) . It thus follows that FGF-3 and FGF-4 expressed in the same cell type and from identical constructs, have distinct modes of action and confer to the EF43 cells an invasive, tumorigenic and metastatic phenotype via signaling pathways that lead to transcriptional activation of distinct genes. Because translocation within the cell has been demonstrated for FGF-1 and 2 (Wiedlocha et al., 1996) , an FGF intracellular signal cannot be excluded as a possible mechanism of action. However, FGF-4 transforms cells through an autocrine loop that involves the extracellular activation of the receptors (Talarico and Basilico, 1991) . Moreover, FGF-3 activates the MAP kinase pathway in cells expressing the appropriate receptors, increasing the phosphorylation of ERK-1, ERK-2 and Raf-1 in cells expressing FGFR-1 and FGFR-2 (Mathieu et al., 1995) . Hence, FGF-3 and FGF-4 are probably acting via the activation of their high anity receptors. In the FGFRs, there is one consensus tyrosine residue that, when phosphorylated, binds phospholipase C g and couples the FGFR to phosphatidylinositol hydrolysis (Mohammadi et al., 1996) . When phosphorylation occurs on other tyrosine residues, the receptors recruit indirectly Grb2/Sos via the FRS2 protein, making a characteristic ternary complex and linking the activated receptor to the ras/ MAPK signaling pathways (Kouhara et al., 1997) . Recently, a very interesting enhancer has been described, the activation of which is restricted to FGF family members (Jaakkola et al., 1997 , who tested FGF-4 but not FGF-3). This enhancer is located far upstream from the activated gene. It binds two FGF-inducible Fos-Jun heterodimers, one inducible AP-2-related protein and two constitutively expressed factors.
In conclusion, the EF43.fgf-3 and EF43.fgf-4 cell system (Table 3) oers the opportunity to study the elements which are involved in (i) the pathways that are activated by FGF-4 and lead to cytoskeleton reorganization, increased motility, anchorage-independent growth and VEGF upregulation, and (ii) the pathways that are activated by FGF-3 and lead to stimulation of both pro-MMP-9 and PAs synthesis.
Materials and methods
Cell cultures
The EF43 parental cells and their retrovirally infected derivatives, were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS, Gibco-BRL, Merelbeke, Belgium), 5 ng/ ml mouse epithelial growth factor (EGF, Sigma, St. Louis, MO) and 1 mg/ml bovine insulin (Boehringer, Mannheim, Germany). Penicillin (100 U/ml) and streptomycin (100 mg/ ml) were added to all media. Cells were grown at 378C in a 5% CO 2 atmosphere. We used the EF43.fgf-3 cells carrying the retroviral plasmid LTR-fgf-3-SV40 early promoter-neo-LTR, the EF43.fgf-4 cells carrying the same construct expect for the presence of fgf-4 and the EF43.C cells harboring the control vector with the neomycin resistance gene only (Hajitou and Calberg-Bacq, 1995) .
EF43.fgf-3 clones and dot blot analysis of fgf-3 expression
In order to compare their tumorigenicity, several EF43.fgf-3 cell clones were isolated with cloning cylinders. One EF43.C cell line was similarly isolated and used as control. Fgf-3 expression in the clones was estimated by dot blotting. Total RNA was extracted by TRIzol (Gibco) and heat denatured at 658C in 106SSC (16SSC is 0.15 M NaCl ± 0.015 M Na-citrate) containing 18.5% formaldehyde. Three serial dilutions were spotted on a nylon membrane using a Schleicher and Schull manifold, immobilized by UV cross-linking and hybridized to a cDNA probe labeled with a-32 PdATP using a random priming labeling kit (Boehringer). Prehybridization and hybridization were performed at 428C in the presence of 40% formamide. Membranes were washed twice at room temperature in 26SSC, 0.1% SDS, and 4 ± 6 times at 658C with decreasing SSC concentrations (26 ± 0.16) containing 0.1% SDS.
The membranes were exposed to X-ray ®lms at 7708C. Signal intensities were estimated by densitometry scanning (Scan Jet 4P, Hewlett-Packard). The fgf-3 probe was the XbaI ± EcoRI fragment from the SP65 int2 plasmid (Smith et al., 1988) . To control RNA loading, the membranes were rehybridized following the same technique (except that hybridization was at 378C and washing was twice at room temperature and once at 378C, all in 26SSC, 0.1% SDS) with an actin cDNA probe (insert fragment from Gem-bactin). The results were expressed by the ratio fgf-3/actin signal intensity.
Conditioned media
To prepare the conditioned media, cells seeded the day before (1.5610 6 in 10 cm plastic dishes), were washed three times with phosphate buered saline (PBS), the last washing being performed after 2 h incubation in serum-free medium at 378C. Conditioning was obtained by a 24 h incubation in 5 ml serum-free medium deprived of insulin and EGF. In some experiments, serum-free medium was supplemented with various concentrations (10, 20, 30, 40 or 50 ng/ml) of 12-O-tetradecanoylphorbol-13-acetate (TPA from Sigma). In some experiments (see Results), culture dishes were coated with type I (from bovine skin) or type IV collagen (from human placenta). Conditioned media were ®ltered through a 0.45 mm ®lter to remove cellular debris. After conditioning, the cells were counted and/or their DNA content was measured in order to compare samples conditioned by the same number of cells (around 8000).
Immuno¯uorescence staining
For FGF-3 detection, cells grown on glass coverslips were ®xed in acetone-methanol (V/V) for 15 min at 7208C and permeabilized with 0.2% Triton X-100 in PBS for 5 min. After saturation in 1.5% skimmed milk in PBS for 30 min at room temperature, the cells were incubated ®rst for 1 h at 378C with a rabbit polyclonal anti-FGF-3 antiserum (kindly provided by Dr C Dickson) at a 1 : 300 dilution and then with a¯uorescein-conjugated swine anti-rabbit IgG (Dako, Copenhagen, Denmark) at a 1 : 30 dilution for 30 min at 378C. For FGF-4-detection, cells were ®xed for 20 min in methanol at 7208C and incubated for 1 h at 378C with a rabbit polyclonal anti-FGF-4 antiserum (kindly provided by Dr C Dickson) at a 1 : 10 dilution then with the¯uorescein-labeled secondary antibody as above.
Expression of a-smooth muscle actin was analysed on ®xed cultured cells using the same technique as for FGF-3 detection but using a monoclonal anti-a-smooth muscle actin (Sigma) diluted 1 : 300 and a secondary¯uorescein-conjugated rabbit anti-mouse antiserum (Dako). For laminin and type IV collagen detection, cells were ®xed with 4% paraformaldehyde, permeabilized with absolute methanol (5 min, 7208C) and incubated (30 min at room temperature) with polyclonal rabbit antisera against laminin or type IV collagen (Foidart et al., 1980) used 1/100 diluted. The secondary antibodies were¯uorescein-conjugated goat antirabbit antiserum (Dako).
Immuno¯uorescence on frozen sections (5 ± 10 mm) was carried out with the same antibodies as those used on ®xed cultured cells. Preparations were counterstained by Evans blue, washed with water, mounted with Fluoprep (BioMeÂ rieux, Marcy l'Etoile, France) and viewed with a Leitz Laborlux microscope or an Olympus-Meridian confocal laser scan microscope.
For cadherin and catenin immuno¯uorescence detection, the cells, grown on coverslips, were washed brie¯y in Ca + and Mg + containing PBS then ®xed for 10 min in methanol at 7208C. After blocking with 5% BSA in Tris-buered saline for 30 min, cells were incubated for 1 h at 378C successively with primary antibodies (DECMA-1 for Ecadherin, anti-a-or anti-b-catenin antisera, all from Sigma), then with biotinylated secondary antibodies (Amersham), then with streptavidin-Texas red (Amersham) and DAPI (4',6' diamidino-2 phenyl-indole, Sigma). Coverslips were mounted in Glycergel (Dako).
Cadherin detection by Western blotting of b-catenin immunoprecipitates
Cells were lysed and samples of equal protein amounts were immunoprecipitated with anti b-catenin antibody as previously described (Vermeulen et al., 1995) . Precipitated proteins were separated by SDS ± PAGE for immunoblotting with a polyclonal pan-cadherin antiserum raised against the peptide CRFKKLADMYGGGEDD coupled to keyhole limpet haemocyanin, recognizing the conserved cytoplasmic tail of classical cadherins (our unpublished results), and revealed as described (Van Hengel et al., 1997) .
Estrogen receptors
The presence of estrogen receptors in the EF43 cells and their derivatives was investigated with the method described by Scatchard (1949), using (6,7- 3 H) estradiol (50 Ci/mmol, TRK125, Amersham Life Science, Buckinghamshire, UK) and diethylstilbestrol (D4628 from Sigma) as cold competitor. Cells (10 6 ) were trypsinized, centrifuged, washed with PBS, suspended in 1 ml PBS and sonicated for 10 s. The extracts were tested for estradiol binding and their protein content was measured by a Bradford's assay. A human breast cancer sample extract having 72 fmol of E2 receptor per mg of total protein, was used as positive control.
Gelatin zymography
Aliquots (5 ± 10 ml) of conditioned media were analysed by quantitative zymography as described by Baramova et al. (1994) . The gelatinolytic activities appeared as transparent bands and could be estimated by laser scanning densitometry. Molecular weight standard proteins (Bio-Rad Laboratories, Hercules, CA) were run simultaneously. Conditioned medium of the human HT-1080 cells producing gelatinases A and B, was used as a control.
Assay of PA and PAI activities
The activities of u-PA, t-PA and PAI were determined using the colorimetric method described by Leprince et al. (1989) . Samples of conditioned media (5 ml) were tested in triplicate. 10 ml of ®brinogen fragments solution were added for the measurement of total PA activity and omitted for the determination of only the u-PA activity. After substraction of the blank, the results were converted in mUnits following the standard u-PA activity curve run in parallel. PAI activities were measured in a modi®ed assay which determines the inhibition of the activity of 5 mUnits human u-PA added to the well.
In vitro cell invasion assays
Precultured heart fragments invasion assay (Mareel et al., 1981) EF43 cells in monolayer pieces were confronted with 9-day old embryonic heart fragments (diameter 0.4 mm). After an overnight incubation on the top of a semi-solid agar, the confronting pairs were cultured in suspension for 4 or 7 days and then ®xed in Bouin Hollande's solution. They were embedded in paran, serially sectioned and stained with hematoxylin and eosine. Histological evaluation was performed by three independent observers and invasion was scored according to Bracke et al. (1993) .
Boyden assays The chemoinvasion assays were performed in Biocat Matrigel invasion chambers (Collaborative Biochemical Products, Becton Dickinson, Bedford, MA, USA) where each ®lter (0.3 cm 2 ) was coated with 38 mg of matrigel. The chambers, kept at 748C, were warmed to room temperature and rehydrated (2.5 h) with 250 ml of serum-free medium. Cells (10 4 ) suspended in 200 ml of serum-free medium containing 0.1% (w/v) BSA (fraction V, Miles, Elkart, IN) were seeded in the upper compartment. In the lower compartment, the chemoattractant was 500 ml of DMEM containing 20% FCS and 1% BSA. The cells were allowed to invade for 36 h (at 378C). The membranes were then rinsed with PBS, ®xed at their lower surface with 4% paraformaldehyde (15 min at 48C), permeabilized with methanol (10 min at 7208C), stained with May-GruÈ nwald (Flucka) for 5 min and then with 4% Giemsa (Flucka) for 15 min. The cells on the membrane upper surface were wiped away with a cotton swab. The ®lter was cut out, mounted in Eukitt and xylol (1-1) and the cells on the total lower surface of the membrane were counted under the microscope. Each cell line was tested twice in triplicate.
Collagen type I invasion assay This assay was performed and the results calculated following the standardized method described by Vakaet et al. (1991) . In brief, 0.22% type I collagen (Biochrom KG, Berlin, Germany) was allowed to gelate in a 9.5 cm 2 well. The cells (10 5 ) in 1.2 ml of complete medium were seeded on top of the collagen gel and allowed to invade for 24 h. Invasion was scored on living cultures using a microscope with a computercontrolled stage. The score was expressed by the invasion index (number of cells inside the gel over total number of cells) and the mean invasion depth.
In vivo tumorigenicity
Cells were trypsinized, counted, centrifuged and resuspended in serum-free medium. Cells (2610 6 in 100 ml) of the various EF43 types were injected either into the mammary fat pad or subcutaneously into syngeneic 4-week-old female Balb/c mice and 4-week-old female nude mice (nu/nu Swiss mice from Ia Credo, L'Arbresle, France). Each mouse received two injections and three ± six mice, as indicated in the results, were used per experimental group. Mice were examined twice a week for tumor appearance or measurement. Tumor growth was determined from caliper measurement of two diameters and expressed as mean diameter increase+s.d.
Metastatic potential
To visualize possible metastases, an EF43 cell population expressing lacZ was ®rst established by infecting EF43 cells with ecotropic retroviral vectors that carry the Bag vector (LTR-lacZ-SV40 early promoter-neo-LTR; Price et al., 1987) . G418-resistant clones were isolated and screened for lacZ expression by in vitro staining for b-galactosidase activity as described below. The best EF43.lacZ clone was ampli®ed and infected with either the fgf-3-or the fgf-4-carrying vectors or the DOBS control vector. To obtain a maximal infection without selection, the EF43.lacZ cell line was submitted to three successive infections using viral supernatants diluted twice (containing 8 mg/ml polybrene and around 10 6 c.f.u. of viruses). LacZ expression was detected as described by Lin et al. (1990) by X-gal (5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside, Boehringer) staining of the cells in culture or whole organs dissected and ®xed immediately after sacri®ce of the mouse. Small samples of stained organs were observed in toto and photographed under a Leitz Laborlux microscope. For histological analysis, cryosections were prepared from the stained organs frozen at 7808C and counterstained with hematoxylin and eosin.
